invest4biotech

SYNSIGHT presents its activity to the 1st edition of Invest4biotech at Genopole among 12 start-ups.

SYNSIGHT introduces its innovative drug discovery platform, which combines artificial intelligence, experimental, and computer-aided drug design to financial sponsors.